Joseph M. Raffaele, MD. Dr. Raffaele received his B.A. in philosophy from Princeton University and his MD from Hahnemann University Medical School in 1989. He did his residency at The New York Hospital/Cornell University Medical Center and was formerly a adjunct clinical assistant professor of medicine at Dartmouth Medical School while in practice at the Hitchcock Clinic. He is a member of the American College of Physicians, is board certified in internal medicine, and is a diplomat of the American Board of Anti-Aging Medicine. In 1995, Dr. Raffaele began researching and developing a scientifically-based treatment program and co-founded PhysioAge Medical Group. Since 1997 he has been practicing age management and bioidentical hormone replacement therapy in his clinical practice.

As a physician focused on understanding the science behind the causes of the effects of the aging process, Dr. Raffaele has always had an interest in telomere biology. In 2006, he became involved in the launch of TA Sciences. In conjunction with several top scientists, he helped analyze the data and develop the Patton Protocol, notably by determining the most applicable biomarkers to use in tracking the effects of the molecule in humans. His clinical practice, PhysioAge Medical Group, acts as the New York City clinical arm of TA Sciences. In that capacity, he oversees the administration of testing, data collection and data preparation for analysis by statisticians. In 2008 PhysioAge became the first licensee of the Patton Protocol. Dr. Raffaele is constantly working with other members of the scientific and medical communities to gain insights into the latest data as it becomes available.